ORIGINAL RESEARCH article
Front. Pharmacol., 16 November 2018
Sec. Cancer Molecular Targets and Therapeutics
Volume 9 - 2018 | https://doi.org/10.3389/fphar.2018.01248
RETRACTED: AFAP1-AS1 Promotes Epithelial-Mesenchymal Transition and Tumorigenesis Through Wnt/β-Catenin Signaling Pathway in Triple-Negative Breast Cancer
- KZ
Kaiming Zhang 1†
- PL
Peng Liu 1†
- HT
Hailin Tang 1†
- XX
Xiaoming Xie 1
- YK
Yanan Kong 1
- CS
Cailu Song 1
- XQ
Xingsheng Qiu 2*
- XX
Xiangsheng Xiao 1*
1. Department of Breast Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China
2. Department of Neurology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China
Summary
Citation
Zhang K, Liu P, Tang H, Xie X, Kong Y, Song C, Qiu X and Xiao X (2018) RETRACTED: AFAP1-AS1 Promotes Epithelial-Mesenchymal Transition and Tumorigenesis Through Wnt/β-Catenin Signaling Pathway in Triple-Negative Breast Cancer. Front. Pharmacol. 9:1248. doi: 10.3389/fphar.2018.01248
Received
15 June 2018
Accepted
12 October 2018
Published
16 November 2018
Retracted
16 January 2026
Volume
9 - 2018
Edited by
Zhi Sheng, Virginia Tech, United States
Reviewed by
Chun Hei Antonio Cheung, National Cheng Kung University, Taiwan; Shiv K. Gupta, Mayo Clinic, United States
Updates
†These authors have contributed equally to this work
This article was submitted to Cancer Molecular Targets and Therapeutics, a section of the journal Frontiers in Pharmacology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.